During the past 25 years, the Joslin Diabetes Center Diabetes Research Center (DRC) has stimulated and nurtured diabetes research at the Joslin and in the surrounding Harvard Medical School community. The DRC, with its Core Laboratories, Enrichment Program, and support for Pilot and Feasibility (P&F) studies, has provided critical infrastructure for basic, translational, and clinical research, and provided an outstanding intellectual enrichment base for diabetes researchers at Joslin and across the Harvard/Longwood medical area. Having a robust and adaptable DRC administrafive structure is critical for maintaining and coordinating the quality, effectiveness, and efficiency of the DRC core services, and for providing the vision that allows the DRC to adapt to changing needs and discoveries in the field of diabetes research especially now to implement the planned expansion of research efforts at Joslin. The purpose of the Joslin Diabetes Center DRC Administrafive Component is to: 1) Manage the DRC in a manner that ensures: a) strength in its leadership, b) quality, efficiency, and oversight in its Cores, and c) promotion of a stimulating, interactive, and collaborative scientific environment that advances diabetes research in the nearby Harvard community and greater Boston area. 2) Adapt to progress in scientific and informafion technology so that: a) the DRC Cores maintain cutting edge relevance with respect to the services they offer and b) information and computing technologies are leveraged to provide maximal efficiency and quality for DRC operations.
The Administrative Component ofthe Joslin Diabetes Center DRC is essenfial to manage the Core Laboratories, Pilot and Feasibility Program and Enrichment Program that facilitate research directed to prevention, better treatments, and a cure for diabetes.
|Pavkov, Meda E; Nelson, Robert G; Knowler, William C et al. (2015) Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int 87:812-9|
|Avadhani, Radhika; Fowler, Kristen; Barbato, Corinne et al. (2015) Glycemia and cognitive function in metabolic syndrome and coronary heart disease. Am J Med 128:46-55|
|Baskaran, Charumathi; Volkening, Lisa K; Diaz, Monica et al. (2015) A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes 16:263-70|
|Rasbach, Lisa; Jenkins, Carolyn; Laffel, Lori (2015) An integrative review of self-efficacy measurement instruments in youth with type 1 diabetes. Diabetes Educ 41:43-58|
|Castiglioni, Alessandra; Hettmer, Simone; Lynes, Matthew D et al. (2014) Isolation of progenitors that exhibit myogenic/osteogenic bipotency in vitro by fluorescence-activated cell sorting from human fetal muscle. Stem Cell Reports 2:92-106|
|Markowitz, Jessica T; Volkening, Lisa K; Laffel, Lori M B (2014) Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr 164:1384-9|
|Isganaitis, Elvira; Woo, Melissa; Ma, Huijuan et al. (2014) Developmental programming by maternal insulin resistance: hyperinsulinemia, glucose intolerance, and dysregulated lipid metabolism in male offspring of insulin-resistant mice. Diabetes 63:688-700|
|Teo, Adrian Kee Keong; Valdez, Ivan Achel; Dirice, Ercument et al. (2014) Comparable generation of activin-induced definitive endoderm via additive Wnt or BMP signaling in absence of serum. Stem Cell Reports 3:5-14|
|Lee, Hyung-Yul; Wei, Dan; Loeken, Mary R (2014) Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy. Diabetes Metab Res Rev 30:23-30|
|Sanders, Kaitlyn; Jung, Jin Hyuk; Loeken, Mary R (2014) Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancy. Birth Defects Res A Clin Mol Teratol 100:584-91|
Showing the most recent 10 out of 706 publications